FDA lifts hold on Ocugen's COVID-19 vaccine trial. But is it too late for the shot?

FDA lifts hold on Ocugen's COVID-19 vaccine trial. But is it too late for the shot?

Source: 
Fierce Pharma
snippet: 

Six weeks after slapping a clinical hold on a trial of Ocugen’s COVID-19 vaccine, the FDA has lifted it. That’s the good news for the Malvern, Pa. company, which has partnered with India’s Bharat Biotech on the shot known commercially as Covaxin.